Green Tea Mood Randomized Trial: What the Evidence Says

Green Tea Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomi

3 min read · 561 wordsReviewed August 2026
Close-up of green tea being poured from a red teapot into a ceramic cup. - Evidence evidence guide for green tea mood randomized trial
Photo by Silvio Pelegrin on Pexels · Pexels License

Quick Answer

Green Tea Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 1 randomized trial, 1 narrative review.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Green Tea Mood Randomized Trial: What the Evidence Says

Quick Answer

Green Tea Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 1 randomized trial, 1 narrative review.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
A Randomized Controlled Trial to Determine the Effects of Curcumin and Epigallocatechin-3-Gallate Supplementation on Serum Brain-Derived Neurotrophic Factor and Mood Disturbance in Adults randomized trial 2 2026-03-06 10.3390/nu18050855
Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities narrative review 3 2026-05-01 10.1002/fsn3.71856

What The Sources Report

  • Pathophysiology has revealed that one of the primary risk factors for depression is chronic stress due to glucocorticoid effects on the hypothalamic-pituitary-adrenal (HPA) axis. [Cavanah Aidan M. (2026); evidence level 2]
  • BDNF exerts neuroprotective and neuroactivating properties on both excitatory and inhibitory neurons, with high concentrations found in the hippocampus and frontal cortex. [Cavanah Aidan M. (2026); evidence level 2]
  • Polyphenols strengthen the intestinal barrier and reduce endotoxemia; cocoa bean shell extracts protected against oxysterol-induced intestinal damage and improved gut microbiota composition in preclinical models (Alia et al. ). [Akif Adnan (2026); evidence level 3]
  • While many epidemiological studies correlate polyphenol-rich diets (e.g., Mediterranean diet) with reduced NCCD risk, causality is uncertain due to confounding and measurement error. [Akif Adnan (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For green tea mood randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

  • Cavanah Aidan M. (2026). A Randomized Controlled Trial to Determine the Effects of Curcumin and Epigallocatechin-3-Gallate Supplementation on Serum Brain-Derived Neurotrophic Factor and Mood Disturbance in Adults. DOI: 10.3390/nu18050855. PMCID: PMC12986582. PMID: 41830024. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12986582/
  • Akif Adnan (2026). Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities. DOI: 10.1002/fsn3.71856. PMCID: PMC13135109. PMID: 42079325. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13135109/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed August 7, 2026 by Migaku Evidence Review

← All GuidesSupplement Reference →